Cargando…
Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Healthcare Infection Society. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833704/ https://www.ncbi.nlm.nih.gov/pubmed/33338560 http://dx.doi.org/10.1016/j.jhin.2020.11.030 |
_version_ | 1783642124093227008 |
---|---|
author | Belvisi, V. Del Borgo, C. Vita, S. Redaelli, P. Dolce, P. Pacella, D. Kertusha, B. Carraro, A. Marocco, R. De Masi, M. Mastroianni, C. Lichtner, M. |
author_facet | Belvisi, V. Del Borgo, C. Vita, S. Redaelli, P. Dolce, P. Pacella, D. Kertusha, B. Carraro, A. Marocco, R. De Masi, M. Mastroianni, C. Lichtner, M. |
author_sort | Belvisi, V. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7833704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Healthcare Infection Society. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78337042021-01-26 Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? Belvisi, V. Del Borgo, C. Vita, S. Redaelli, P. Dolce, P. Pacella, D. Kertusha, B. Carraro, A. Marocco, R. De Masi, M. Mastroianni, C. Lichtner, M. J Hosp Infect Practice Points The Healthcare Infection Society. Published by Elsevier Ltd. 2021-03 2020-12-15 /pmc/articles/PMC7833704/ /pubmed/33338560 http://dx.doi.org/10.1016/j.jhin.2020.11.030 Text en © 2020 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Practice Points Belvisi, V. Del Borgo, C. Vita, S. Redaelli, P. Dolce, P. Pacella, D. Kertusha, B. Carraro, A. Marocco, R. De Masi, M. Mastroianni, C. Lichtner, M. Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? |
title | Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? |
title_full | Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? |
title_fullStr | Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? |
title_full_unstemmed | Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? |
title_short | Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? |
title_sort | impact of sars cov-2 pandemic on carbapenemase-producing klebsiella pneumoniae prevention and control programme: convergent or divergent action? |
topic | Practice Points |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833704/ https://www.ncbi.nlm.nih.gov/pubmed/33338560 http://dx.doi.org/10.1016/j.jhin.2020.11.030 |
work_keys_str_mv | AT belvisiv impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT delborgoc impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT vitas impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT redaellip impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT dolcep impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT pacellad impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT kertushab impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT carraroa impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT maroccor impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT demasim impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT mastroiannic impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT lichtnerm impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction AT impactofsarscov2pandemiconcarbapenemaseproducingklebsiellapneumoniaepreventionandcontrolprogrammeconvergentordivergentaction |